Department of Gastroenterology and Hepatology, Soonchunhyang University School of Medicine, Seoul, Korea.
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
Gut Liver. 2018 Nov 15;12(6):714-721. doi: 10.5009/gnl18271.
BACKGROUND/AIMS: Recently reported prognostic models for primary biliary cholangitis (PBC) have been shown to be effective in Western populations but have not been well-validated in Asian patients. This study aimed to compare the performance of prognostic models in Korean patients and to investigate whether inflammation-based scores can further help in prognosis prediction.
This study included 271 consecutive patients diagnosed with PBC in Korea. The following prognostic models were evaluated: the Barcelona model, the Paris-I/II model, the Rotterdam criteria, the GLOBE score and the UK-PBC score. The neutrophil-to-lymphocyte ratio (NLR) was analyzed with reference to its association with prognosis.
For predicting liver transplant or death at the 5-year and 10-year follow-up examinations, the UK-PBC score (areas under the receiver operating characteristic curve [AUCs], 0.88 and 0.82) and GLOBE score (AUCs, 0.85 and 0.83) were significantly more accurate in predicting prognosis than the other scoring systems (all p<0.05). There was no significant difference between the performance of the UK-PBC and GLOBE scores. In addition to the prognostic models, a high NLR (>2.46) at baseline was an independent predictor of reduced transplant-free survival in the multivariate analysis (adjusted hazard ratio, 3.74; p<0.01). When the NLR was applied to the prognostic models, it significantly differentiated the prognosis of patients.
The UK-PBC and GLOBE scores showed good prognostic performance in Korean patients with PBC. In addition, a high NLR was associated with a poorer prognosis. Including the NLR in prognostic models may further help to stratify patients with PBC.
背景/目的:最近报道的原发性胆汁性胆管炎(PBC)预后模型在西方人群中表现有效,但在亚洲患者中尚未得到很好的验证。本研究旨在比较这些预后模型在韩国患者中的表现,并探讨炎症评分是否能进一步有助于预后预测。
本研究纳入了韩国 271 例连续诊断为 PBC 的患者。评估了以下预后模型:巴塞罗那模型、巴黎 I/II 模型、鹿特丹标准、GLOBE 评分和英国 PBC 评分。分析了中性粒细胞与淋巴细胞比值(NLR)与预后的关系。
在预测 5 年和 10 年随访时的肝移植或死亡风险方面,英国 PBC 评分(ROC 曲线下面积[AUC],0.88 和 0.82)和 GLOBE 评分(AUC,0.85 和 0.83)在预测预后方面明显优于其他评分系统(均 p<0.05)。英国 PBC 评分和 GLOBE 评分的性能无显著差异。除了预后模型外,基线时 NLR 较高(>2.46)也是多变量分析中无移植生存时间缩短的独立预测因素(调整后的危险比,3.74;p<0.01)。当 NLR 应用于预后模型时,它显著区分了患者的预后。
英国 PBC 评分和 GLOBE 评分在韩国 PBC 患者中表现出良好的预后性能。此外,高 NLR 与预后较差相关。将 NLR 纳入预后模型可能有助于进一步分层 PBC 患者。